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ABSTRACT
Subcutaneous anticoagulant medications like Heparin and Low-Molecular Weight
Heparin are injections that readily cause bruising, pain, induration, and hematoma formation at
the injection site. It is known that these adverse reactions can be correlated to the technique used
to administer these medications; however, there is no established technique that reduces bruising,
pain, induration, and hematoma formation at the site. Currently, the only protocol for
subcutaneous Heparin and Low-Molecular Weight Heparin is that it is to be administered
subcutaneously in the abdomen and when using a prefilled syringe, the air bubble should not be
removed. The purpose of this study was to identify current nursing practice for the
administration of these medications and to compare the results to researched techniques that
resulted in less adverse site reactions. A total of 33 participants were recruited. The survey
targeted six researched techniques found, after a comprehensive literature review, to have
reduced site adverse effects associated with subcutaneous Heparin and Low-Molecular Weight
Heparin. After completing the survey, it was found that current practice does not reflect
techniques researched to reduce bruising, pain, induration, and hematoma formation at the site.
In fact, very few completed one of the six research techniques that were questioned, which
included: a two minute application of a cold compress/pack before and/or after the injection, an
injection duration lasting 30 seconds, slow removal of the needle over five seconds, application
of pressure after the injection for a minimum of 30 seconds, use of a hot pack/compress after the
injection, and the use of a3 mL syringe. It was also found that there were inconsistencies in
techniques that have been previously established as current protocol for these medications.
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CHAPTER 1: INTRODUCTION
A venous thromboembolism is a clot that develops in at risk patients and can lead to a
pulmonary embolism, pulmonary hypertension, chronic venous insufficiency, stroke, or
myocardial infarction, which can ultimately result in death (Wipke-Tevis & Rich, 2011). Heparin
and Low Molecular Weight Heparins (LMWH) (i.e Enoxaparin, Reviparin, and Nadroparin) are
prophylactic anticoagulant injections administered subcutaneously for the prevention of such
thrombi. Heparin works by activating the enzyme antithrombin III, while LMWH’s potentiate
the effects of antithrombin on factor Xa and thrombin. Both inhibit thrombin and prolong
coagulation time, ultimately preventing the enlargement of pre-existing clots and the formation
of new clots (Adams & Urban, 2013; Vallerand, Sanoski, & Deglin, 2011).
Administration of subcutaneous Heparin and LMWH can lead to hematoma formation,
local site induration, and often causes bruising and pain at the injection site (Prater, Lenox,
Renner, Tallmadge, & Von Lunen, 2013; Zaybak & Khorshid, 2008). Bruising, induration, and
hematoma formation at the injection site can consequently limit the availability of that site for
future injections and cause physiological discomfort to the patient (Kuzu & Ucar, 2001). Pain
and bruising can also cause anxiety, disruption of body image, and patient rejection of
subsequent injections (Avsar & Kasikci, 2013).
Akpinar and Celebioglu (2008), Palese, Aidone, Dante, and Pea (2013), and
Pourghaznein, Azimi, and Jafarabadi (2014) agree that these adverse reactions at the injection
site are directly related to the technique used to administer these medications; however, there is
no standard technique to administer Heparin and LMWH that reduces the likeliness of these
adverse reactions from occurring. Current protocol is that Heparin and LMWH medications are
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to be administered subcutaneously, preferably in the abdomen, and if the medication is provided
via a prefilled syringe from the pharmacy, the air bubble is not to be removed; no further
instructions are provided. The abdomen is used for proper absorption, and air bubbles are in the
provided prefilled syringes to prevent leaking of Heparin or LMWH through the subcutaneous
tissue and onto the skin surface (Wooldridge & Jackson, 1988).
Standard subcutaneous injection techniques include: washing hands and cleansing the
injection site prior to administration, angle insertion of needle between 45 and 90 degrees
depending on the amount of subcutaneous tissue that is able to be pinched, insertion of needle
into subcutaneous tissue without aspiration, and application of gentle pressure, ensuring the site
is not rubbed or massaged after medication is injected slowly (Hall, 2013). How long pressure
should be held and over how many seconds the medication should be injected for subcutaneous
injections is not indicated.
Injection techniques that reduce bruising, pain, induration and hematoma formation at the
injection site have been researched. They have not been adopted as the standard practice for
administering these medications. Therefore, the purpose of this study is to identify what current
nursing practice is for administering Heparin and LMWH, and how current techniques compare
to researched techniques that reduce site adverse reactions. This study was conducted via an
emailed electronic and voluntary survey administered to nurses on the University of Central
Florida’s Theta Epsilon chapter of Sigma Theta Tau Honor Society of Nursing list-serve and the
University of Central Florida’s graduate nursing program list-serve.
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CHAPTER 2: REVIEW OF LITERATURE
Injection Duration and Needle Removal
Zaybak and Khorshid (2008) studied the effect of duration of the injection on bruising
and pain on 50 patients who were hospitalized on neurology, orthopedic and cardiology units.
Heparin was injected for 10 seconds on the right side of the abdomen and for 30 seconds on the
left side. Bruising occurred in 64% (32) of the patients who received the injection over 10
seconds compared to only 42% (21) who received the 30-second injection time. The mean
bruising size for the control group was 109.20 mm2 48 hours after the injection and 110.12
mm2 72 hours after the injection. The mean bruising size for the experimental group was,
respectively, 18.76 and 21.72 mm2 . Pain was significantly reduced in intensity and length in
those who received the experimental injection.
Palese, Aidone, Dante, and Pea (2013) conducted a similar study that also looked at
injection duration effects on bruising and pain on 15 patients with 300 injections total. They too
compared a 10 second injection to a 30 second injection. Out of 300 injections, 87 bruises were
observed: 57 of 150 occurred after injecting the medication over 10 seconds and 30 of 150
occurred after injecting the medication over 30 seconds. Palese, Aidone, Dante, and Pea,
however, found no difference in bruise size between the two treatments. The average size
difference between the 10 second injection and the 30 second injection was 0.095 mm2 .
Pourghaznein, Azimi, and Jafarabadi (2013) conducted a study that analyzed injection
duration and also needle removal time on 90 patients on two intensive care units (ICU). Using
four different methods, each patient received four injections in the thighs and abdomen. The
abdomen was divided into four quadrants and one out of the four methods (A, B, C, D) was used
3

in each of the quadrants. The thighs were sectioned into upper and lower parts. Methods A and B
were in the right thigh and methods C and D were in the left.
Method A included injecting the medication over 10 seconds, method B included
injecting the medication over 10 seconds and waiting 10 seconds before withdrawing the needle,
method C included injecting the medication over 15 seconds and waiting five seconds before
withdrawing the needle, and method D included injecting the medication over five seconds and
waiting 15 seconds before withdrawing the needle. Method C resulted in the lowest frequency of
bruising in the abdomen (24), compared to method A in the thigh that resulted in bruising in 40.
The researchers found no significant difference in number and size of bruising in the injection
methods between the abdomen and thighs; however, pain was significantly more severe in the
thighs than the abdomen.
Akpinar and Celebioglu (2008) did a similar study that also looked at injection duration
and also needle removal time effects on bruising in 36 patients. Method A included injecting the
medication over 10 seconds, method B included injecting the medication over 30 seconds, and
method C included injecting the medication over 10 seconds, but waiting 10 seconds before
withdrawing the needle. Bruising occurred in 22 patients with the use of method B and 23
patients using method C, compared to 32 bruises in method A. Bruising diameter was also
reduced in methods B and C with an average of 35-55 mm2 , while the average diameter for
method A was 110 mm2 .
Indications for use.
The reduction in pain that is observed when administering an injection slowly (over 30
seconds) occurs because tissue damage is reduced. The giving strength of the drug is reduced
4

during a slower injection. Also, injecting these medications under lower pressure (over 30
seconds) may result in less tissue trauma, contributing to lower occurrence of bruising (Zaybak
& Khorshid, 2006). The reduced occurrence and extent of bruising that is seen when needle
removal is prolonged (five seconds) occurs because it allows proper time for heparin absorption
and prevents drug backflow, which results in bruising (Akpinar & Celebioglu, 2008). It is
protocol to give Heparin and LMWH in the abdomen, unless contraindicated.
Cold and Hot Application
Kuzu and Ucar (2000) investigated the effects of a dry cold application on the occurrence
of bruising, hematoma formation, and pain on 63 patients. Method A there was no cold
application (17), method B a cold application was applied to the injection site five minutes prior
to the injection (16), method C a cold application was applied to the injection site five minutes
after the injection (15), and in method D a cold application was applied to the injection site five
minutes prior to the injection and five minutes after (15). A total of 466 injections were
evaluated at the 48 hour mark and 421 injections were evaluated at the 72 hour mark for
bruising. A total of 539 injections were evaluated for pain immediately after injection.
With regards to bruising, there was no statistical difference among the methods; however,
with regards to pain, pain intensity and duration was significantly less in methods B and D. In
method B, only 26 out of 119 (21.8%) experienced moderate pain, while, in method A, 47 out of
156 experienced moderate pain (30.1%). In method D, 27 out of 106 (25.5%) actually
experienced no pain compared to only 9 out of 119 (5.8%) in method A.
The previous study was based on Ross and Soltes’ (1995) study of ice and its effects on
hematoma formation and patient discomfort in 70 patients. The population was used as their own
5

control as each were given two injections 12 hours apart. For one of the injections, ice was
applied for two minutes prior and after the injection. Their results showed no significant
difference in incidence or size of hematoma, though, perception of pain was severely reduced.
Conversely, Akpinar (2013) studied the effects of a local dry heat application on bruising
incidence and recovery in 33 patients. LMWH was injected into both of the upper arms. One of
the patient’s upper arms with bruising was used as the control group, and the other arm with
bruising was the experimental with an application of a dry heat pack 72 hours after the injection.
In the experimental arm, the mean size of bruising sites was 4.54 ± 4.33 cm² before the
heat application and was 3.21 ± 3.78 cm² after the heat application, respectively compared to the
control arm which was 6.01 ± 5.47 cm² and 5.22 ± 4.45 cm².
Indications for use.
The application of a dry cold pack for a minimum of two minutes before and after
injection is believed to create an ice analgesia effect locally on the injection site (Ross & Soltes,
1995); thereby, altering pain perception. The use of a hot pack on the injection site can speed
bruising recovery. Furthermore, decreasing patient anxiety, improving body image, and
increasing adherence to treatment. It is believed that the use of a heat application after 48-72
hours past the time of injection increases blood circulation to the affected area via vasodilation,
ultimately accelerating cell metabolism rate, the inflammation process, and tissue recovery time
(Akpinar, 2013).
Application of Pressure
McGowan and Wood (1989) investigated the application of pressure and aspiration
effects on bruising incidence in 95 patients using four different methods. Aspiration is not
6

included in current protocol for administration of Heparin and LMWH, because these
medications are given subcutaneously. This study was conducted prior to this adopted standard.
For method A pressure was applied to the injection site for two minutes after the injection,
method B no pressure was applied, method C the syringe was aspirated and pressure was applied
for two minutes after the injection, and method D the syringe was aspirated. It was concluded
that the evidence did not significantly support the hypothesis that the application of pressure
reduced bruising size or occurrence. Despite the results of this study, Akpinar and Celebioglu
(2008), Pourghaznein, Azimi, and Jafarabadi (2014), and Kuzu and Ucar (2001) included
applying light pressure without rubbing the site after injections in their control groups for their
studies of administration techniques.
Available textbooks for nursing students include instructions on how to administer
Heparin and LMWH with the only significant difference from standard subcutaneous injections
being to apply pressure for an extended period of time. Prater, Lenox, Renner, Tallmadge, and
Von Lunen (2013), in RN Pharmacology for Nursing, instruct students to apply pressure to the
injection site for one to two minutes after the injection. Potter, Perry, and Desmarais (2015), in
Mosby’s Pocket Guide to Nursing Skills & Procedures place significance for the student nurse to
administer these medications over several seconds without moving the syringe, and to apply
pressure for 30 to 60 seconds.
Indications for use.
McGowan and Wood (1989) believe that the application of pressure causes manual
vasoconstriction, and prevents the leakage of blood from superficial blood vessels that are
traumatized during needle insertion. Potter, Perry, and Desmarais (2015) also provide a rationale
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for extended pressure application. They, too, state that pressure significantly reduces bruising at
the injection site. Because it is included in standard subcutaneous injection protocol, pressure
should be applied after injection. For Heparin and LMWH, the amount of time to apply pressure
can be concluded to a minimum of 30 seconds.
Syringe Size
Hadley, Chang, and Rogers (1996) studied the effects of syringe size on bruising in 29
patients. Subjects received injections in a 1 mL or 3 mL syringe in a randomized sequence, and
sites were assessed for bruises 24, 48, and 72 hours after injection. Bruising occurred in 69% of
patients who received injections in a 3 mL syringe compared to 79% in a 1 mL syringe. Bruising
size was also significantly larger with the use of the 1 mL syringe and over-time the sizing of the
bruise increased compared to the 3 mL syringe. The mean bruise size for the 3 mL syringe was
about 20 mm², while the 1 mL syringe produced an average bruise size of 38 mm² 24 hours after
the injection. 72 hours after the injection, the size of the bruising for the 1 mL syringe increased
to 70 mm² and decreased for the 3 mL syringe to about 10 mm².
Wooldridge and Jackson (1988) studied the effects of syringe size, change of needle and
the use of an air bubble on bruising and induration occurrence on 50 patients with cardiovascular
disorders. Method A included the use of a 3 mL syringe, an air bubble, and changing of needle,
and method B included the use of a 1 mL syringe, without an air bubble or changing of needle
for drawing Heparin into the syringe. Induration occurred twice in each of the methods, and
bruising frequency was not found to be significantly different. The size of bruising, however,
was different. For method A, mean bruising size for females was 38 mm², while method B
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resulted in a mean of 50 mm². For men, bruising was smaller but there was a still a statistical
difference. Respectively, bruising mean was 0.036 mm² and 2.1 mm².
Indications for use.
Previously, it was recommended to use a tuberculin syringe (1 mL) to provide accurate
dosing for Heparin and LMWH, currently, Heparin is typically provided in prefilled syringes
distributed by hospital pharmacy. However, there is a possibility of having to manually draw up
Heparin and LMWH. The use of a 3 mL syringe when prefilled Heparin and LMWH syringes
are not distributed results in less tissue trauma. When the area of a syringe is increased, the force
of the substance within the syringe decreases causing less blunt trauma to vessels and tissue. This
ultimately results in a decrease in bruising size (Hadley, Chang, & Rogers 1996).
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CHAPTER 3: METHODS
Design and Instrument
This descriptive exploratory correlational study was conducted using an electronic,
voluntary and anonymous survey. Survey questions were created from researched techniques,
standard subcutaneous injection protocol, and current Heparin and LMWH protocol and allowed
for multiple choice answering and free-text answers. The survey analyzed the six different
researched techniques discussed in Chapter 2 and are as follows:
1. Corresponds to question 7: The use of a cold pack for two minutes before and/or
after injection to reduce site pain.
2. Corresponds to question 12: Injection duration over 30 seconds to reduce pain and
tissue trauma.
3. Corresponds to question 13: Slow removal of needle (five seconds) to allow
absorption of medication to occur to prevent bruising.
4. Corresponds to question 15: Applying pressure for a minimum of 30 seconds to
reduce bruising by providing manual vasoconstriction.
5. Corresponds to question 16: Applying a hot pack to site after injection to promote
quicker healing of bruises.
6. Corresponds to questions 17 and 18: The use of a 3 mL syringe if the employer
does not offer prefilled syringes with Heparin and LMWH to reduce bruising.
Questions one through four ask non-identifying demographic data. Other questions not
included in the above explanation were deemed to be standard protocol for subcutaneous
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injections and/or current protocol for subcutaneous Heparin and LMWH injections or were
placed to enhance survey fluidity and consistency.
A copy of the survey can be found in Appendix C.
A table comparing standard techniques for administration versus researched suggested
techniques can be found in Appendix D.
Human Subjects
Approval was requested from the University of Central Florida’s Institutional Review
Board (IRB), and the study was determined as not human research. Participants remained
anonymous throughout the study and surveys were not linked with any identifying information.
Participants were able to withdraw from the study at any time without penalty.
Sample and Setting
A convenience sample of nurses from the Theta Epsilon chapter of the nursing honor
society Sigma Theta Tau at the University of Central Florida and from the graduate nursing
program at the University of Central Florida were invited to participate in the survey. Nurses
were required to be at least 18 years of age, to have administered subcutaneous Heparin or
LMWH before, and to have worked directly in patient care within the past five years. 37
participants started the survey and 33 completed the survey. Surveys that were not completed
were not included in the study. The participants were able to complete the survey once at a
computer that allowed access to the email invitation.
Procedures
A draft email with an invitation to participate in this study was sent to the leading
representative of each organization. The leading representatives emailed the invitation with a
11

web-link to the self-administered survey and an explanation of research (Appendix B) on the
researchers’ behalves to the nurses on the list-serves for the Theta Epsilon chapter of Sigma
Theta Tau and graduate nursing program at the University of Central Florida. The survey was
closed electronically after two weeks.
Measurements
The measure used in this study was a survey created by the researchers adapted from
researched techniques and standard protocols.
The survey was divided into two sections with the first section including demographic
data, educational background, and years of experience as a nurse. The second section of the
survey allowed for multiple choice answering and/or free-text to assess what current practice is
for administering subcutaneous injections of Heparin and LMWH.
Descriptive statistics of the survey were completed in 2015 Research Suite, Qualtrics.
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CHAPTER 4: RESULTS
Demographic Data
A total of 33 nurses from both list-serves participated in this study. The sample was 9%
(n=3) male and 91% female (n=30) with ages ranging from less than 35 years of age (55%;
n=18), 35-50 years of age (30%; n=10), and greater than 50 years of age (15%; n=5). Results
indicated 24% (n=8) of the nurses had been practicing for 6-12 months, 6% (n=2) had been
practicing for 1-2 years, 42% (n=14) of the nurses had been practicing for 2-10 years, and 27%
(n=9) of then nurses had been practicing for greater than 10 years. None of the nurses had a
Diploma or an Associate’s Degree in nursing, 67% (n=22) had a Bachelor’s of Science Degree in
Nursing, 30% (n=10) had a Master’s Degree in Nursing, and one nurse (3%) had a Doctor of
Philosophy in Nursing.
Quantitative Analysis
In regards to standard nursing practice for the administration of subcutaneous injections,
question five asked about hand washing prior to injection, question six asked about cleansing of
the injection site prior to the injection, question 10 asked if the nurse aspirated, and question 14
asked if the nurse rubbed the site after injecting the medication. Results indicated 91% (n=30)
stated that they did wash their hands prior to administering the injection, 97% (n=32) clean the
site with an alcohol swab prior to injection, and 3% (n=1) clean the site with a chlorhexidine
swab, 9% (n=3) indicated that they do aspirate for this injection and 91% (n=30) stated that they
do not aspirate for this injection, and 100% (n=33) stated that they do not rub the site after giving
the injection.
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The survey asked two questions about standard protocol for administering Heparin and
LMWH subcutaneously, including: question eight that asks about where the nurses administer
these medications and question 11 that asks if they remove the air bubble prior to administering
these medications if the nurses are using a prefilled syringe. Results indicated 100% (n=33)
administer this medication in the abdomen, and 67% (n=22) do not remove the air bubble when
using a prefilled syringe, 30% (n=10) stated that they do remove the air bubble, and one (3%)
nurse said they were not sure if they removed the air bubble.
For fluidity, question nine was inserted and asked about how quickly or slowly does the
participant insert the needle into the subcutaneous tissue. Results indicated 73% (n=24) stated
quickly averaging less than three seconds, 3% (n=1) stated they insert the needle slowly over
three seconds, and 24% (n=8) indicated that they inject the needle without regard for time.
Researched injection techniques that were reported to reduce pain, bruising, hematoma
formation and/or pain at the injection site were asked and included: application of an ice pack
(question seven), time taken to inject the medication (question 12), needle removal time
(question 13), application of pressure after administration of the medication (question 15),
application of a hot pack after the injection (question 16), and syringe size (questions 17 and 18).
Results indicated 100% (n=33) stated that they do not use any type of cold application
pre- or post-injection. A total of 79% (n=26) inject the medication over 10 seconds or less, 9%
(n=3) stated that they inject the medication between 11-29 seconds, 3% (n=1) indicated that they
inject the medication over 30 seconds, and 9% (n=3) were unsure for how many seconds they
inject the medication. A total 64% (n=21) stated they remove the needle quickly averaging less
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than three seconds, 15% (n=5) stated they remove the needle slowly averaging between two to
five seconds, and 21% (n=7) remove the needle without regard for time.
A total of 15% (n=5) stated they apply pressure for less than 10 seconds, 6% (n=2) apply
pressure for 10-29 seconds, 6% (n=2) apply pressure for 30-59 seconds, 0% apply pressure for
60 seconds or longer, and 73% (n=24) stated that they do not apply pressure to the site after
injection. A total of 100% (n=33) stated they do not apply a dry heat pack/compress to the
injection site after administering the injection.
A total of 91% (n=30) stated that at their work place, subcutaneous Heparin and LMWH
medications are administered in a prefilled syringe, and 9% (n=3) said no. A total of 67% (n=22)
stated they use a prefilled syringe and that self-preparation of the medication was not available,
9% (n=3) stated that when prefilled syringes are not available, they use a 1 mL syringe, 21%
(n=7) stated that when prefilled syringes are not available, they use a 3 mL syringe, and one
(3%) nurse stated they were not sure what syringe size they use when a prefilled syringe is not
available.

15

CHAPTER 5: DISCUSSION
Current Practice
A breakdown by question is provided below to identify current nursing practice for the
administration of subcutaneous Heparin and LMWH. It begins with five, corresponding to the
number of the question on the survey. Current practice was determined by what the majority of
nurses selected as the answer for each question.
5. Nurses wash their hands prior to the administration of subcutaneous anticoagulant
medications.
6. Nurses cleanse the injection site with an alcohol swab prior to injecting these
medications.
7. Nurses do not apply an ice-pack, cold compress, or cold-pack to the injection site
prior/post medication injection.
8. Nurses administer these medications in the subcutaneous tissue of the abdomen.
9. Nurses insert the needle quickly into the subcutaneous tissue, averaging less than three
seconds.
10. Nurses do not aspirate.
11. Nurses do not remove the air bubble.
12. Nurses inject the medication into the tissue over 10 seconds or less.
13. Nurses remove the needle quickly from the tissue after injection, averaging less than
three seconds.
14. Nurses do not rub the site after injecting these medications.
15. Nurses do not apply pressure after administering these medications.
16

16. Nurses do not use a dry heat-pack or compress on the site after injecting the
medication.
17 & 18. Lastly, most nurses work at a facility in which prefilled syringes are used;
however, if prefilled is not available, a majority of nurses will use a 1 mL syringe.
Subcutaneous Injection Techniques
A majority of the nurses participating in the survey understood what techniques are used
when administering subcutaneous injections. This is considered fundamental nursing knowledge
and is typically taught early in nursing curriculum. All of the nurses cleansed the injection site
prior to injection and did not rub the site after administering the injection. Depending on area of
practice, nurses administer subcutaneous injections daily and are expected (despite area of
practice) to administer subcutaneous injections per protocol; however, three nurses stated that
they do aspirate and three separate nurses stated that they do not wash their hands prior to
administering LMWH and Heparin. This means 18% (n=6) of the nurses taking the survey do not
administer LMWH and Heparin per standard subcutaneous injection protocol.
Heparin and LMWH Injection Protocol
All nurses who participated in the survey administer Heparin and LMWH in the
subcutaneous tissue of the abdomen; however, there was discrepancy as whether or not to
remove the air bubble found in prefilled syringes. As stated previously, the air bubble is to not be
removed as general protocol for Heparin and LMWH. Of the 33 participants, 30% (n=10)
remove the air bubble, 67% (n=22) do not remove the air bubble, and one nurse was unsure if
they remove the bubble. There was no demographic correlation among participants with similar
answers for this question.
17

Researched Techniques
A majority of nurses are not administering Heparin and LMWH according to previously
researched techniques to reduce bruising, pain, induration and hematoma formation at the site of
injection; therefore, increasing the likelihood of the occurrence of these adverse reactions.
All participants stated that they do not use any type of cold or hot application to the
injection site. A cold application is recommended prior/after the injection to provide an analgesic
effect, and a hot application is recommended several hours after the injection to promote healing
of bruises. A majority of the nurses stated that they inject the medication over 10 seconds or less,
contrary to the recommended 30 second researched technique, and majority of the nurses also
stated that they do not apply any sort of pressure compared to the recommendation of applying
pressure for a minimum of 30 seconds. Also, a majority of the nurses stated that they remove the
needle quickly from the tissue after injection (averaging less than three seconds), compared to
the recommended technique of slow removal after five seconds. Lastly, a majority of the nurses
use a prefilled syringe at their employer institution, and when asked if prefilled syringes were not
used, a majority stated they used a 1 mL syringe. A 3 mL syringe is recommended to reduce
blunt trauma to surrounding tissue.
There were no correlations among age, years as a nurse, or degree type that suggested a
relationship among answers.
Limitations
The sample size was small and included nurses from one University institution, limiting
the generalizability of the study results. Due to limited time available, only 33 nurses participated
in the study and their employer institution was not known. Nurses surveyed from a hospital unit
18

that regularly gives Heparin and LMWH would have been beneficial, but not plausible due to
time constraints. A larger sample size that targets nurses who administer Heparin and LMWH at
a national level would yield more accurate results.
Recommendations for Practice and Education
In regards to standard administration protocol for subcutaneous injections and
subcutaneous Heparin and LMWH, there was apparent discrepancy and possible confusion. It
would be beneficial to provide continuing education about standard subcutaneous injections and
infection control. Minimally, areas of practice should also provide education about established
techniques for subcutaneous anticoagulant medications, including not to remove the air bubble.
In regards to researched techniques, nurses are not administering Heparin and LMWH
medications using techniques that are suggested to reduce bruising, pain, induration, and
hematoma formation at the injection site. It is important for nurses to be educated about research
that enhances evidence based practice. Introduction to techniques that can reduce bruising should
be provided to nurses and providers administering subcutaneous anticoagulant therapies since
reduction of bruising, induration, and hematoma formation at the site enhances the ability for the
site to be used in future injections.
Also, by reducing pain experienced with Heparin and LMWH, nurses can build more
trusting relationships with patients, reduce anxiety, and promote a healthy body image in the
patient. Techniques that should be included are: injecting the medication over 30 seconds and
prolonging the removal of the needle by five seconds, applying a cold pack to the injection site
prior and/or post injection for two minutes, application of a heat pack 48-72 hours after injection,
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application of pressure at the site for 30 seconds after medication injection and needle removal,
and the use of a 3 mL syringe when prefilled syringes are not available.
Finally, because there was no correlation among demographic data and answers,
evaluation of course material about Heparin and LMWH injection technique education in schools
should be evaluated. Findings thus suggest that because there is no discrepancy among
demographic data, current education about these medications are insufficient. As stated
previously, student nurses should be minimally taught the standard practice for administering
these medications; however, introduction to researched techniques should be incorporated into
the curriculum.
Recommendations for Future Research
There is much research that can be conducted to provide evidence to support the best
practice for administration of subcutaneous Heparin and LMWH. Further research of the above
stated techniques should be completed for validity and for clarity (i.e. how long to apply pressure
for). Furthermore, a technique that encompasses all of the techniques stated above should be
examined and considered for adoption as the established practice for these medications. Results
would indicate whether or not these practices do in fact result in a decrease of injection site
adverse reactions associated with Heparin and LMWH.
Research should also be conducted to see why there is confusion about current
established protocol for subcutaneous Heparin and LMWH. Results can be used to provide
clarity as to why there is confusion and provide a way of means for reducing the confusion.
Research should also be conducted about standard subcutaneous injection technique knowledge
in nurses. This study indicated that 18% of nurses do not administer Heparin and LMWH as a
20

standard subcutaneous injection, and further research is warranted to establish why this has
occurred.
Lastly, research should be conducted about current educational requirements that include
subcutaneous Heparin and LMWH to identify reasoning as to why nurses are not administering
this medication according to standard protocol. Results would indicate needed interventions in
the educational curriculum that would promote the use of the standard techniques as these
techniques are recommended per manufacturer protocol.
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CHAPTER 6: CONCLUSION
Current nursing practice for the administration of subcutaneous anticoagulant
medications reflects proper subcutaneous injection technique, but yields some confusion about
current Heparin and LMWH protocol. Current protocol includes administering the medication as
a standard subcutaneous injection, specifically in the abdomen, and to not remove the air bubble
that is found when using a prefilled syringe. Current nursing practice when compared to
researched techniques suggested to reduce site adverse reactions does not reflect researched best
practice. In fact, very few nurses actually completed any one of the recommended techniques.
The suggested techniques included: using a cold application before and/or after the injection to
provide an ice analgesic effect, injecting the medication over 30 seconds to cause less tissue
trauma, slowly removing the needle over five seconds to reduce medication leaking onto skin
surface, application of pressure for a minimum of 30 seconds to create manual vasoconstriction,
using a hot application/pack 48-72 hours after the injection to speed up the healing process of the
damaged tissue from the injection, and using a 3 mL syringe when prefilled syringes are not
provided. Lastly, generally nurses are administering subcutaneous Heparin and LMWH similarly
to each other.
Recommendations include providing educational courses, seminars, etc. on standard
protocol for the administration of subcutaneous Heparin and LMWH, and introduction of
researched techniques suggested to reduce site adverse reactions to current nurses to enhance
evidence based practice. Another recommendation includes modification of student nursing
curriculum and/or education to include proper administration techniques of these medications
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and introduction to the researched techniques so that they may become familiar with it after
becoming a practicing nurse.
Research should be conducted on the six different techniques to enhance the techniques’
validity in reduction of site adverse reactions. Research should also be conducted to determine
why there is confusion about standard subcutaneous injections and standard protocol for the
administration of subcutaneous Heparin and LMWH, and to identify why student nurses are not
learning the proper techniques for these medications and, consequently, not administering this
medication properly once they have become a nurse.
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EXPLANATION OF RESEARCH
Title of Project: Injection Techniques of Subcutaneous Anticoagulant Therapies
Principal Investigator: Kelly Allred, PhD, RN-BC, CNE
Other Investigators: Co-Investigator- Leah Morissette, Undergraduate Nursing Student
Faculty Supervisor: Principal Investigator
You are being invited to take part in a research study. Whether you take part is up to you..


There is currently no universal technique to administer subcutaneous anticoagulant therapies (i.e Lovenox)
that results in the reduction of the possible adverse reactions pain and bruising at the injection site. The
purpose of this survey is to identify current techniques being utilized by nurses for the administration of
anticoagulant therapies.



The survey is electronic and can be accessed by following the provided link. Please fill out the demographic
data for the first part of the survey. The second part of the survey will require you to answer questions about
administering anticoagulant therapy. Please answer as to what you do when administering this medication.
There are no correct answers. Select the best answer possible.



The questionnaire should take no more than 5 minutes to complete.



The survey will be available for two weeks, at the end of this time period all participants who provide their
email address within the survey will be entered into a drawing to receive 1 of possible 20 availble $5
Starbucks gift cards.

You must be 18 years of age or older, a Registered Nurse, have provided direct patient care (i.e. being a floor nurse)
within the past five years, and have administered subcutaneous anticoagulant therapies (i.e Lovenox, Low-Molecular
Weight Heparin, etc.).
Completion of the survey will imply your consent to participate in this research study.
Study contact for questions about the study or to report a problem: If you have questions, concerns, or complaints,
contact Dr. Kelly Allred, Faculty Supervisor, College of Nursing at 407-823-0160 or by email at Kelly.Allred@Ucf.edu
IRB contact about your rights in the study or to report a complaint: Research at the University of Central Florida
involving human participants is carried out under the oversight of the Institutional Review Board (UCF IRB). This research
has been reviewed and approved by the IRB. For information about the rights of people who take part in research, please
contact: Institutional Review Board, University of Central Florida, Office of Research & Commercialization, 12201 Research
Parkway, Suite 501, Orlando, FL 32826-3246 or by telephone at (407) 823-2901.
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Demographics
1. Gender:


Male



Female

2. Age in years:


<35



35-50



>50

3. Years as a nurse:


6-12 Months



1-2 Years



2-10 Years



>10 years

4. Educational background:


Diploma



Associate Degree in Nursing



Bachelor of Science in Nursing



Master Degree in Nursing



Other (Please Specify Below)
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Survey Questions
5. Prior to administration of this medication, do you wash your hands?


Yes



No

6. How do you prepare the injection site prior to administering the medication?


I clean the area with an alcohol swab



I clean the area with soap and water



Other



I do not prepare the site prior to injection

7. Do you apply an ice-pack, cold compress, or cold-pack to the site prior or after injecting the
medication?


Yes, before (please specify type and for how long)



Yes, after (please specify type and for how long)



I do not use any type of cold application pre- or post- injection

8. Where do you administer this medication?


In the subcutaneous tissue of the arm



In the subcutaneous tissue of the leg



In the subcutaneous tissue of the abdomen

9. With regards to time, how do you insert the needle into the subcutaneous tissue?


Quickly (please specify in seconds)



Slowly (please specify in seconds)



I inject the needle without regard for time



Other
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10. Do you aspirate?


Yes



No

11. Do you remove the air bubble prior to administering the medication when using a pre-filled
syringe?


Yes, I remove the air bubble



No, I do not remove the air bubble



I'm not sure

12. For how long do you inject the medication from the syringe into the subcutaneous tissue?


For 10 seconds or less



Between 11-29 seconds



For 30 seconds or longer



I'm not sure for how long I inject the medication

13. With regards to time, how do you remove the needle from the subcutaneous tissue?


Quickly (please specify in seconds)



Slowly (please specify in seconds)



I remove the needle without regard for time



Other

14. Do you rub the site after injecting the medication?


Yes, for less than 30 seconds



Yes, for 30 seconds or longer



No
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15. Do you apply pressure to the injection site after administering the medication?


Yes, for less than 10 seconds



Yes, for 11-29 seconds



Yes, for 30-59 seconds



Yes, for 60 seconds or longer



No, I do not apply pressure

16. Do you apply a dry heat-pack or compress to the injection site after injecting the medication?


Yes (please specify type and for how long)



No

17. At your work place, are subcutaneous anticoagulant therapies distributed in a prefilled
syringe?


Yes



No



I’m not sure

18. If therapies are not distributed in a prefilled syringe, what syringe size (mL) do you use?


N/A (Use prefilled syringe)



3 mL



1 mL



Other



I’m not sure
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Standard Techniques for
Administering Subcutaneous
Heparin and LMWH


Standard subcutaneous injection
protocol



To not remove the air bubble before
administration of the medication when
using a prefilled syringe



Researched Techniques Suggested to
Reduce Site Adverse Reactions

Administer subcutaneously in the
abdomen
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Two minute cold pack/compress
before and/or after injecting the
medication



Injecting the medication over 30
seconds



Slowly removing the needle from the
tissue for over 5 seconds



Application of pressure at the injection
site after removing the needle from the
tissue for a minimum of 30 seconds



Application of a hot pack/compress
48-72 hours after the injection



Use of a 3 mL syringe when prefilled
syringes are not available

APPENDIX E: DEMOGRAPHIC DATA
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1. Gender:
Selection

Answer

Response

%

1
2

Male
Female
Total

3
30
33

9%
91%
100%

2. Age in years:
Selection

Answer

Response

%

1
2
3

18-34
35-50
>50
Total

18
10
5
33

55%
30%
15%
100%

Response

%

8

24%

2
14
9
33

6%
42%
27%
100%

3. Years as a nurse:
Selection

1
2
3
4

Answer

6-12
Months
1-2 Years
2-10 Years
>10 years
Total

4. Educational background:
Selection

1
2

3

4

5

Answer

Diploma
Associate
Degree in
Nursing
Bachelor of
Science in
Nursing
Master
Degree in
Nursing
Other
(Please
Specify
Below)
Total
Other (Please Specify Below)

PhD

36

Response

%

0

0%

0

0%

22

67%

10

30%

1

3%

33

100%
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5. Prior to administration of subcutaneous anticoagulant therapies, do you wash
your hands?
Selection

1
2

Answer

Yes
No
Total

Response

%

30
3
33

91%
9%
100%

6. How do you prepare the injection site prior to administering the medication?
Selection

1

2
3
4

Answer

I clean the
area with an
alcohol
swab
I clean the
area with
soap and
water
Other
I do not
prepare the
site prior to
injection
Total
Other

clorohexidine swab

38

Response

%

32

97%

0

0%

1

3%

0

0%

33

100%

7. Do you apply an ice-pack, cold compress, or cold-pack to the site prior or
after injecting the medication?
Selection

1

2

3

Answer

Yes, before
(please
specify type
and for how
long)
Yes, after
(please
specify type
and for how
long)
I do not use
any type of
cold
application
pre- or postinjection

Response

%

0

0%

0

0%

33

100%

Response

%

0

0%

0

0%

33

100%

33

100%

8. Where do you administer this medication?
Selection

1

2

3

Answer

In the
subcutaneous
tissue of the
arm
In the
subcutaneous
tissue of the
leg
In the
subcutaneous
tissue of the
abdomen
Total

39

9. With regards to time, how do you insert the needle into the subcutaneous
tissue?
Selection

1

2

3

4

Answer

Response

%

24

73%

1

3%

8

24%

0
33

0%
100%

Quickly
(please
specify in
seconds)
Slowly
(please
specify in
seconds)
I inject the
needle
without
regard for
time
Other
Total
Quickly (please specify in
seconds)

Slowly (please specify in
seconds)

3s
15
1
.5
1
1
2 seconds
1
1
0.5
1-3
1-2 seconds
1
3
1-2
5
1
1
2
1
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10. Do you aspirate?
Selection

1
2

Answer

Yes
No
Total

Response

%

3
30
33

9%
91%
100%

11. Do you remove the air bubble prior to administering the medication when
using a pre-filled syringe?
Selection

1

2
3

Answer

Yes, I
remove the
air bubble
No, I do not
remove the
air bubble
I'm not sure
Total

Response

%

10

30%

22

67%

1
33

3%
100%

12. For how long do you inject the medication from the syringe into the
subcutaneous tissue?
Selection

1
2
3

4

Answer

For 10
seconds or
less
Between 1129 seconds
For 30
seconds or
longer
I'm not sure
for how long
I inject the
medication
Total

41

Response

%

26

79%

3

9%

1

3%

3

9%

33

100%

13. With regards to time, how do you remove the needle from the
subcutaneous tissue?
Selection

1

2

3

4

Answer

Response

%

21

64%

5

15%

7

21%

0
33

0%
100%

Quickly
(please
specify in
seconds)
Slowly
(please
specify in
seconds)
I remove the
needle
without
regard for
time
Other
Total

Quickly (please specify in
seconds)

15
1
1
2
2 seconds
1
1-3
2
1 second
2 seconds
2
1
2
1
1
2
1

Slowly (please specify in
seconds)

5
2
3
3s
2
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14. Do you rub the site after injecting the medication?
Selection

1

2
3

Answer

Yes, for less
than 30
seconds
Yes, for 30
seconds or
longer
No
Total

Response

%

0

0%

0

0%

33
33

100%
100%

15. Do you apply pressure to the injection site after administering the
medication?
Selection

1
2
3
4

5

Answer

Yes, for less
than 10
seconds
Yes, for 1029 seconds
Yes, for 3059 seconds
Yes, for 60
seconds or
longer
No, I do not
apply
pressure
Total

Response

%

5

15%

2

6%

2

6%

0

0%

24

73%

33

100%

16. Do you apply a dry heat-pack or compress to the injection site after injecting
the medication?
Selection

1
2

Answer

Yes (please
specify type
and for how
long)
No
Total

43

Response

%

0

0%

33
33

100%
100%

17. At your work place, are subcutaneous anticoagulant therapies distributed in
a prefilled syringe?
Selection

1
2
3

Answer

Yes
No
I'm not sure
Total

Response

%

30
3
0
33

91%
9%
0%
100%

18. If therapies are not distributed in a prefilled syringe, what syringe size (mL)
do you use?
Selection

1
2
3
4
5

Answer

N/A (Use
prefilled
syringe)
3 mL
1 mL
Other
I'm not sure
what syringe
size I use
Total

44

Response

%

22

67%

3
7
0

9%
21%
0%

1

3%

33

100%
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